Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joan Merrill, M.D.
Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program
Study ChairKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucla Medical Center: Division of Rheumatology
Los Angeles, California, United States
- Yale University School of Medicine: Rheumatology, Allergy & Immunology
New Haven, Connecticut, United States
- Emory University School of Medicine: Division of Rheumatology
Atlanta, Georgia, United States
- Piedmont Healthcare: Rheumatology Atlanta
Atlanta, Georgia, United States
- Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases
Boston, Massachusetts, United States
- Feinstein Institute for Medical Research: Center for Autoimmune and Musculoskeletal Diseases
Manhasset, New York, United States
- Columbia University Medical Center: Department of Medicine, Division of Rheumatology
New York, New York, United States
- University of North Carolina at Chapel Hill; Thurston Arthritis Research Center: Division of Rheumatology, Allergy, and Immunology
Chapel Hill, North Carolina, United States
- Oklahoma Medical Research Foundation: Arthritis and Clinical Immunology Research Program
Oklahoma City, Oklahoma, United States
- Pennstate Health Milton S. Hershey Medical Center: Division of Rheumatology
Hershey, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2022
- Primary completion
- 13 Jun 2024
- Completion
- 11 Jul 2024
- Last update posted
- 9 Sept 2025
- Registered enrollment
- 12
- Registry id
- NCT05306873
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.